Risk assessment models: thromboprophylaxis & VTE recurrence
ISTH Academy. Presenters F. 09/26/19; 304487

Lara Roberts

Sabine Eichinger
Learning Objectives
Risk Assessment Models
September 26, 2019 13:00 - 14:00 UTC
Speakers:
Lara Roberts "Thromboprophylaxis"
· To understand the role of venous thromboembolism (VTE) risk assessment
· To appropriately identify patients who require VTE risk assessment
· To review the available VTE risk assessment models, with a focus on the VTE prevention approach in England
Sabine Eichinger "VTE Recurrence"
· Identify risk factors of recurrent deep vein thrombosis and pulmonary embolism
· Estimate the recurrence risk in a patient after a deep vein thrombosis or pulmonary embolism
· Determine the optimal duration of anticoagulation in such patients
Moderator: Sigrid Brækkan
September 26, 2019 13:00 - 14:00 UTC
Speakers:
Lara Roberts "Thromboprophylaxis"
· To understand the role of venous thromboembolism (VTE) risk assessment
· To appropriately identify patients who require VTE risk assessment
· To review the available VTE risk assessment models, with a focus on the VTE prevention approach in England
Sabine Eichinger "VTE Recurrence"
· Identify risk factors of recurrent deep vein thrombosis and pulmonary embolism
· Estimate the recurrence risk in a patient after a deep vein thrombosis or pulmonary embolism
· Determine the optimal duration of anticoagulation in such patients
Moderator: Sigrid Brækkan
{{ help_message }}
{{filter}}